On the NHS, liraglutide is still listed for specialist Tier 3 weight management services under NICE guidance (TA664), but its now rarely the first choice, having been largely replaced by Wegovy and Mounjaro
Novo Nordisk followed the design concept of liraglutide to ensure that the peptide sequence is as consistent as possible with natural GLP-1, while focusing on the selection of fatty acid side chains
It necessitated Mojsov injecting her lab-made peptides into rabbits once a week for three consecutive weeks to encourage their immune systems to produce specific antibodies against them which took about two months to happen (Mojsov, Heinrich, Wilson)
If budget allows, this is the most targeted option for semaglutide users who want to enhance their GLP-1 response
Clinical features range from asymptomatic to acute respiratory distress syndrome (ARDS) and multi-organ dysfunction
Slow escalation significantly reduces early gastrointestinal symptoms and increases the likelihood of sustained therapy